Clinical and laboratory features of patients with CLL
| Patient no. . | Sex . | Age, y . | Rai stage . | ZAP70* . | FISH† . | TP53 . |
|---|---|---|---|---|---|---|
| 1 | F | 82 | 1 | Absent/low | 13q− | Mut (exon V) |
| 2 | M | 66 | 4 | Interm/high | ND | WT |
| 3 | M | 65 | 1 | Absent/low | Nor | WT |
| 4 | M | 68 | 4 | Interm/high | 12+ | WT |
| 5 | F | 62 | 0 | Absent/low | Nor | WT |
| 6 | M | 64 | 1 | Absent/low | 13q−/11q− | WT |
| 7 | M | 67 | 2 | Interm/high | 17p− | WT |
| 8 | F | 78 | 2 | Absent/low | 11q− | WT |
| 9 | M | 51 | 0 | Absent/low | Nor | WT |
| 10 | F | 59 | 0 | Absent/low | Nor | WT |
| 11 | M | 69 | 2 | Absent/low | 13q−/17p− | WT |
| 12 | M | 40 | 4 | Interm/high | 11q− | WT |
| 13 | M | 74 | 2 | Interm/high | 13q− | WT |
| 14 | M | 62 | 4 | Interm/high | 17p− | WT |
| 15 | M | 62 | 0 | Absent/low | 11q− | WT |
| 16 | M | 69 | 2 | Absent/low | 17p− | Mut (exon VII) |
| 17 | F | 79 | 3 | Absent/low | 12+ | WT |
| 18 | M | 61 | 2 | Interm/high | 17p− | WT |
| 19 | M | 63 | 4 | Absent/low | 13q− | WT |
| 20 | M | 60 | 4 | Absent/low | 17p− | WT |
| 21 | M | 59 | 2 | Absent/low | 13q− | WT |
| 22 | M | 64 | 1 | Interm/high | 13q− | WT |
| 23 | M | 57 | 1 | Absent/low | 12+ | WT |
| 24 | M | 67 | 4 | ND | ND | WT |
| 25 | F | 68 | 2 | Interm/high | 17p− | Mut (exon V) |
| 26 | F | 55 | 0 | Absent/low | ND | WT |
| 27 | M | 61 | 2 | Absent/low | 17p− | Mut (exon VI) |
| Patient no. . | Sex . | Age, y . | Rai stage . | ZAP70* . | FISH† . | TP53 . |
|---|---|---|---|---|---|---|
| 1 | F | 82 | 1 | Absent/low | 13q− | Mut (exon V) |
| 2 | M | 66 | 4 | Interm/high | ND | WT |
| 3 | M | 65 | 1 | Absent/low | Nor | WT |
| 4 | M | 68 | 4 | Interm/high | 12+ | WT |
| 5 | F | 62 | 0 | Absent/low | Nor | WT |
| 6 | M | 64 | 1 | Absent/low | 13q−/11q− | WT |
| 7 | M | 67 | 2 | Interm/high | 17p− | WT |
| 8 | F | 78 | 2 | Absent/low | 11q− | WT |
| 9 | M | 51 | 0 | Absent/low | Nor | WT |
| 10 | F | 59 | 0 | Absent/low | Nor | WT |
| 11 | M | 69 | 2 | Absent/low | 13q−/17p− | WT |
| 12 | M | 40 | 4 | Interm/high | 11q− | WT |
| 13 | M | 74 | 2 | Interm/high | 13q− | WT |
| 14 | M | 62 | 4 | Interm/high | 17p− | WT |
| 15 | M | 62 | 0 | Absent/low | 11q− | WT |
| 16 | M | 69 | 2 | Absent/low | 17p− | Mut (exon VII) |
| 17 | F | 79 | 3 | Absent/low | 12+ | WT |
| 18 | M | 61 | 2 | Interm/high | 17p− | WT |
| 19 | M | 63 | 4 | Absent/low | 13q− | WT |
| 20 | M | 60 | 4 | Absent/low | 17p− | WT |
| 21 | M | 59 | 2 | Absent/low | 13q− | WT |
| 22 | M | 64 | 1 | Interm/high | 13q− | WT |
| 23 | M | 57 | 1 | Absent/low | 12+ | WT |
| 24 | M | 67 | 4 | ND | ND | WT |
| 25 | F | 68 | 2 | Interm/high | 17p− | Mut (exon V) |
| 26 | F | 55 | 0 | Absent/low | ND | WT |
| 27 | M | 61 | 2 | Absent/low | 17p− | Mut (exon VI) |